LOS ANGELES, Jan....
18( Xinhua)--Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV( SHIV) in a placebo-controlled proof-of-concept study, according to the U.S. National Institutes of Health( NIH). The study intended to inform development of a preventive HIV vaccine for people. The antibodies--a human broadly neutralizing antibody and two antibodies isolated from previously vaccinated monkeys--target the fusion peptide, a site on an HIV surface protei
综合
星报-世界
2024-01-19 00:00:00.0